Amsterdam Molecular Therapeutics BV receives global rights to develop and commercialize AMT-020 for acute intermittent porphyria
Rights from University of Navarra, Pamplona, Spain strengthen AMT's portfolio of gene therapy products
Advertisement
Amsterdam Molecular Therapeutics BV (AMT) announced that it has obtained exclusive worldwide rights to develop and commercialise AMT-020 as a therapeutic product from UTE CIMA, Proyecto de Biomedicina CIMA, S.L. and Digna Biotech (all parties part of the University of Navarra, Pamplona, Spain).
The licence allows AMT to initiate the clinical development of AMT-020 to treat acute intermittent porphyria. This follows successful collaboration between CIMA and AMT, demonstrating the safety and preclinical efficacy of the product, AMT-020. AMT-020 is an AAV vector gene therapy containing the porphobilinogen deaminase gene which encodes for the enzyme that is defective in acute intermittent porphyria. This disease is associated with recurrent attacks of abdominal pain, gastrointestinal dysfunction, and neurologic disturbances.
Other news from the department science
Most read news
More news from our other portals
See the theme worlds for related content
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Topic world Gene therapy
Genetic diseases once considered untreatable are now at the center of innovative therapeutic approaches. Research and development of gene therapies in biotech and pharma aim to directly correct or replace defective or missing genes to combat disease at the molecular level. This revolutionary approach promises not only to treat symptoms, but to eliminate the cause of the disease itself.
Last viewed contents
Presence of nicotine and antidepressants detected in Antarctic waters - A study with the participation of IDAEA and IGME locates organic contaminants derived from human activity in inland and coastal waters of the frozen continent
Reverse negative impact of ultraviolet radiation on skin
Learning from Nature: How a fungus makes a hard job easier - Researchers analyze a fungal biosynthetic pathway and discover a capable enzyme
Anatomical barriers shield the brain from SARS-CoV-2 invasion at vulnerable interfaces - Absence of evidence for neurotropism and neuroinvasion of several SARS-CoV-2 variants including Omicron
Exposure to air pollution before and after birth may affect fundamental cognitive abilities
Insilico Medicine-led study combines quantum computing and generative AI for drug discovery - “Quantum computing is recognized as the next technology breakthrough which will make a great impact, and the pharmaceutical industry is believed to be among the first wave of industries benefiting from the advancement”
A clear path to better insights into biomolecules - 3D images with record-breaking resolution
Revolutionizing cancer research with diamonds
Heavy water tastes sweet - But not to mice
Ebola: New studies model a deadly epidemic
